Inducible Amp C β-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)

Diagnostic Microbiology and Infectious Disease

Volumn 28, Issue 4, 1997, Pages 211-219

  Pfaller, Michael A ^a   Jones, Ronald N ^a   Marshall, Steven A ^a   Coffman, Stacy L ^a   Hollis, Richard J ^a   Edmond, Michael B ^b   Wenzel, Richard P ^b  

^a UNIVERSITY OF IOWA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CIPROFLOXACIN; ENZYME INHIBITOR; GENTAMICIN; IMIPENEM; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD; CITROBACTER FREUNDII; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CEFTAZIDIME; CITROBACTER FREUNDII; CROSS INFECTION; CYCLIC AMP; DATA COLLECTION; DRUG RESISTANCE, MICROBIAL; ENTEROBACTER; EPIDEMIOLOGY, MOLECULAR; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTICENTER STUDIES; SEROEPIDEMIOLOGIC STUDIES; SERRATIA MARCESCENS; UNITED STATES;

EID: 0030801938     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00064-3     Document Type: Article

References (24)

1. Ballow CH, Schentag JJ (1992) Trends in antimicrobial utilization and bacterial resistance: Report of the National Resistance Surveillance Group. Diagn Microbiol Infect Dis 15(suppl):37S-42S.
2. Brown EH, Spencer RC, Brown JMC (1990) The emergence of bacterial resistance in hospitals: A need for continuous surveillance. J Hasp Infect 125(suppl A):35-39.
3. Burwen DR, Banerjee SN, Gaynes RP, the National Nosocomial Infections Surveillance System (1994) Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J Infect Dis 170: 1622-1625.
4. DeGheldre Y, Maes N, Rost F, DeRyck R, Clevenbergh P, Vincent JL, Struelens MJ (1997) Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol 35:152-160.
5. Ehrhardt AF, Sanders CC (1993) β-lactam resistance amongst Enterobacter species. J Antimicrob Chemother 32(suppl B):1-11.
6. Gallagher PG (1990) Enterobacter bacteremia in pediatric patients. Rev Infect Dis 12:808-812.
7. Gaston MA (1988) Enterobacter. An emerging nosocomial pathogen. J Hasp Infect 11:197-208.
8. Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29(suppl A): 19-24.
9. Jones RN (1992) The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens. Diagn Microbiol Infect Dis 15(suppl):3S-10S.
10. Jones RN, Kehrberg EN, Erwin ME, Andersen SC, and the Fluoroquinolone Resistance Surveillance Group (1994) Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Study on the threat of emerging resistance: Real or perceived? Diagn Microbiol Infect Dis 19:203-215.
11. Jones RN, Baquero F, Privitera G, Inoue M, Wiedemann B (1997) Inducible β-lactamase-mediated resistance to third-generation cephalosporins. Clin Microbiol Infect. 3(suppl 1):S7-S20.
12. Livermore DM (1995) β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557-584.
13. National Committee for Clinical Laboratory Standards (1997) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, M7-A4, 4th ed. Wayne, PA: National Committee for Clinical Laboratory Standards.
14. Papasian CJ, Kinney J, Coffman S, Hollis RJ, Pfaller MA (1996) Transmission of Citrobacter koseri from mother to infant documented by ribotyping and pulsed-field gel electrophoresis. Diagn Microbiol Infect Dis 26:63-67.
15. Pfaller MA, Hollis RJ, Sader HS (1994) Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In Clinical Microbiology Procedures Handbook, Supplement 1. Ed, HD Isenberg. Washington, DC: American Society for Microbiology, pp 10.5.c.1-10.5.c.12.
16. Pfaller MA, Wendt C, Hollis RJ, Wenzel RP, Fritschel SJ, Neubauer JJ, Herwaldt LA (1996) Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent Gram-negative bacteremia. Diagn Microbiol Infect Dis 25:1-8.
17. Pitout JDD, Moland ES, Sanders CC, Thomson KS, Fitzsimmons SR (1997) β-Lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrob Agents Chemother 41:35-39.
18. Quinn JP (1994) Clinical significance of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1:39-42.
19. Sanders CC (1984) β-lactamase and non-hydrolytic resistance mechanisms. J Antimicrob Chemother 13:1-3.
20. Sanders CC, Sanders WE (1986) Type 1 β-lactamases of Gram-negative bacteria: Interactions with β-lactam antibiotics. J Infect Dis 159:792-800.
21. Sanders CC, Sanders WE Jr (1988) Clinical and epidemiological implications for use of newer cephalosporins. Rev Infect Dis 10:830-836.
22. Snydman DR (1991) Clinical implications of multi-drug resistance in the intensive care unit. Scand J Infect Dis 22(suppl 78):54-63.
23. Stapleton P, Shannon K, Phillips I (1995) The ability of β-lactam antimicrobials to select mutants with derepressed β-lactamase synthesis from Citrobacter freundii. J Antimicrob Chemother 36:483-496.
24. Voelker R (1996) New group tracks hospital's drug-resistant bugs. JAMA 275:177-178.